Dolby Laboratories, Inc.
DLB
$67.48
$1.973.01%
NYSE
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.77% | 19.84% | -6.17% | 1.26% | 537.60% |
| Total Depreciation and Amortization | 0.79% | 15.05% | 17.57% | 20.21% | 0.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.69% | 63.54% | -6.80% | 19.35% | -27.34% |
| Change in Net Operating Assets | -2,862.04% | 51.25% | -6.40% | 87.32% | -107.77% |
| Cash from Operations | 5.73% | 218.34% | -3.59% | 1,169.82% | 36.65% |
| Capital Expenditure | -120.14% | 15.57% | 22.64% | -11.15% | 9.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.42% | 100.00% | 277.64% | -- | 2,129.74% |
| Cash from Investing | 91.61% | 16.99% | 244.88% | -1,386.10% | -1,225.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 600.56% | 23.81% | -64.08% | 16.47% | -93.21% |
| Repurchase of Common Stock | -71.30% | -13.25% | -38.81% | 58.59% | 21.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.42% | -10.21% | -10.84% | -10.49% | -10.78% |
| Other Financing Activities | 96.24% | 86.47% | -- | 29.32% | -- |
| Cash from Financing | -6.55% | -4.01% | -46.90% | 53.99% | -40.47% |
| Foreign Exchange rate Adjustments | -101.53% | 764.88% | 175.22% | -205.48% | 218.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.32% | 113.61% | 19.87% | 131.02% | -1,168.07% |